0001127602-20-013334.txt : 20200406
0001127602-20-013334.hdr.sgml : 20200406
20200406171440
ACCESSION NUMBER: 0001127602-20-013334
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200402
FILED AS OF DATE: 20200406
DATE AS OF CHANGE: 20200406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FONTEYNE PAUL R.
CENTRAL INDEX KEY: 0001727550
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 20777723
MAIL ADDRESS:
STREET 1: C/O RESTORBIO, INC.
STREET 2: 501 BOYLSTON STREET SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
form3.xml
PRIMARY DOCUMENT
X0206
3
2020-04-02
1
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001727550
FONTEYNE PAUL R.
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
/s/ David Watson, attorney-in-fact for Paul Fonteyne
2020-04-03